EUVIMEDEUVIMED entdecken
Crossref

Protective effect of trans-sodium crocetinate on nephrotoxicity induced by cisplatin: in vitro and in vivo models

Danial Esmaeilzadeh, Mohammad Shariati Rad, Majid Keshavarzi, Homa Fazeli Kakhki, Hossein Hosseinzadeh, Abolfazl Khajavi Rad, Sakineh Amoueian, Bibi Marjan Razavi

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-02 · 399 (3) · 3925-3941

DOI: 10.1007/s00210-025-04633-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 11.10.2025. Verfasst von Danial Esmaeilzadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Cisplatin, Kidney, Antineoplastic Agents, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trans-sodium crocetinate (TSC), a novel derivative of crocetin, has demonstrated potential protective effects against oxidative stress and apoptosis. This study aims to investigate the protective effect of TSC against cisplatin-induced nephrotoxicity by evaluating both in vivo and in vitro models. In the in vivo model, rats were pretreated with TSC (2.5, 5, and 10 mg/kg) for 5 days. Cisplatin (20 mg/kg) was injected on the 5th day to induce nephrotoxicity followed by TSC administration for an additional 2 days. Blood urea nitrogen (BUN) and serum creatinine (sCr) levels were measured to assess kidney function. Histopathological examinations and assessment of oxidative stress were conducted to evaluate renal tissue injury. In the in vitro model, HEK-293 cells were treated with cisplatin (150 µM) both with and without TSC pretreatment. Cell viability, reactive oxygen species (ROS) production, and apoptosis were subsequently evaluated. TSC significantly reduced BUN and sCr levels in rats exposed to cisplatin. Histopathological analysis revealed a reduction in tubular necrosis and other pathological changes associated with cisplatin toxicity. TSC also decreased MDA levels and increased GSH content in renal tissue. In HEK-293 cells, TSC pretreatment enhanced cell viability, reduced ROS production, and suppressed apoptosis by decreasing the Bax/Bcl-2 ratio and the expression of caspase-3 protein. TSC effectively protects against cisplatin-induced nephrotoxicity and cytotoxicity by reducing oxidative stress and apoptosis. These findings highlight TSC's potential as a therapeutic agent to mitigate the nephrotoxic effects of cisplatin in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinKidneyAntineoplastic AgentsKidney DiseasesCarotenoidsAntioxidantsProtective AgentsAnimalsHumansHEK293 CellsOxidative StressMaleApoptosisReactive Oxygen SpeciesVitamin ARatsCreatinineBlood Urea NitrogenCell SurvivalRats, Sprague-Dawley

Stichwörter der Autor:innen

ApoptosisCisplatinCytotoxicityNephrotoxicityOxidative stressTrans-sodium crocetinate

Substanzen

Cisplatintrans-sodium crocetinateReactive Oxygen SpeciesVitamin AAntineoplastic AgentsCarotenoidsCreatinineAntioxidantsProtective Agents

Autor:innen und Institutionen

  • School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pathology, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Zitieren

APA

Esmaeilzadeh, D., Shariati Rad, M., Keshavarzi, M., Fazeli Kakhki, H., Hosseinzadeh, H., Khajavi Rad, A., Amoueian, S., & Razavi, B. M. (2026). Protective effect of trans-sodium crocetinate on nephrotoxicity induced by cisplatin: in vitro and in vivo models. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(3), 3925-3941. https://doi.org/10.1007/s00210-025-04633-7

Vancouver

Esmaeilzadeh D, Shariati Rad M, Keshavarzi M, Fazeli Kakhki H, Hosseinzadeh H, Khajavi Rad A, et al. Protective effect of trans-sodium crocetinate on nephrotoxicity induced by cisplatin: in vitro and in vivo models. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(3):3925-3941. doi:10.1007/s00210-025-04633-7

BibTeX
@article{Esmaeilzadeh2026,
  author = {Esmaeilzadeh, Danial and Shariati Rad, Mohammad and Keshavarzi, Majid and Fazeli Kakhki, Homa and Hosseinzadeh, Hossein and Khajavi Rad, Abolfazl and Amoueian, Sakineh and Razavi, Bibi Marjan},
  title = {Protective effect of trans-sodium crocetinate on nephrotoxicity induced by cisplatin: in vitro and in vivo models},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {3},
  pages = {3925--3941},
  doi = {10.1007/s00210-025-04633-7}
}
Kostenlos starten →